The ErbB4 ligand neuregulin-4 protects against experimental necrotizing enterocolitis.

PubWeight™: 0.87‹?›

🔗 View Article (PMID 25216938)

Published in Am J Pathol on September 09, 2014

Authors

Steven J McElroy1, Shannon L Castle2, Jessica K Bernard3, Dana Almohazey3, Catherine J Hunter4, Brandon A Bell2, Denise Al Alam2, Larry Wang5, Henri R Ford2, Mark R Frey6

Author Affiliations

1: Division of Neonatology, Department of Pediatrics, University of Iowa, Iowa City, Iowa.
2: Division of Pediatric Surgery, Department of Surgery, University of Southern California Keck School of Medicine, Los Angeles, California.
3: Department of Pediatrics, University of Southern California Keck School of Medicine and The Saban Research Institute at Children's Hospital Los Angeles, Los Angeles, California.
4: Departments of Surgery and Pediatrics, Ann and Robert H. Lurie Children's Hospital, Northwestern University, Chicago, Illinois.
5: Department of Pathology, University of Southern California Keck School of Medicine, Los Angeles, California.
6: Department of Pediatrics, University of Southern California Keck School of Medicine and The Saban Research Institute at Children's Hospital Los Angeles, Los Angeles, California; Department of Biochemistry and Molecular Biology, University of Southern California Keck School of Medicine, Los Angeles, California. Electronic address: mfrey@chla.usc.edu.

Articles cited by this

Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche. Nature (2009) 19.18

Necrotizing enterocolitis. N Engl J Med (2011) 6.88

Breast milk and neonatal necrotising enterocolitis. Lancet (1991) 6.38

Long-term expansion of epithelial organoids from human colon, adenoma, adenocarcinoma, and Barrett's epithelium. Gastroenterology (2011) 6.36

WW domain-containing protein YAP associates with ErbB-4 and acts as a co-transcriptional activator for the carboxyl-terminal fragment of ErbB-4 that translocates to the nucleus. J Biol Chem (2003) 3.65

Restriction of intestinal stem cell expansion and the regenerative response by YAP. Nature (2012) 3.54

Feeding strategies for premature infants: beneficial outcomes of feeding fortified human milk versus preterm formula. Pediatrics (1999) 2.69

Cronobacter gen. nov., a new genus to accommodate the biogroups of Enterobacter sakazakii, and proposal of Cronobacter sakazakii gen. nov., comb. nov., Cronobacter malonaticus sp. nov., Cronobacter turicensis sp. nov., Cronobacter muytjensii sp. nov., Cronobacter dublinensis sp. nov., Cronobacter genomospecies 1, and of three subspecies, Cronobacter dublinensis subsp. dublinensis subsp. nov., Cronobacter dublinensis subsp. lausannensis subsp. nov. and Cronobacter dublinensis subsp. lactaridi subsp. nov. Int J Syst Evol Microbiol (2008) 2.62

Redundant sources of Wnt regulate intestinal stem cells and promote formation of Paneth cells. Gastroenterology (2012) 2.57

Colon-specific delivery of a probiotic-derived soluble protein ameliorates intestinal inflammation in mice through an EGFR-dependent mechanism. J Clin Invest (2011) 2.16

System-wide investigation of ErbB4 reveals 19 sites of Tyr phosphorylation that are unusually selective in their recruitment properties. Chem Biol (2008) 1.97

ErbB-4: mechanism of action and biology. Exp Cell Res (2003) 1.91

Mortality of necrotizing enterocolitis expressed by birth weight categories. J Pediatr Surg (2009) 1.90

Human enteric defensins. Gene structure and developmental expression. J Biol Chem (1996) 1.82

Impaired differentiation and lactational failure of Erbb4-deficient mammary glands identify ERBB4 as an obligate mediator of STAT5. Development (2003) 1.79

Epidermal growth factor reduces the development of necrotizing enterocolitis in a neonatal rat model. Am J Physiol Gastrointest Liver Physiol (2002) 1.75

Expression of inducible nitric oxide synthase and interleukin-12 in experimental necrotizing enterocolitis. J Surg Res (2000) 1.72

Incidence and timing of presentation of necrotizing enterocolitis in preterm infants. Pediatrics (2012) 1.65

Postoperative outcomes of extremely low birth-weight infants with necrotizing enterocolitis or isolated intestinal perforation: a prospective cohort study by the NICHD Neonatal Research Network. Ann Surg (2005) 1.63

Transactivation of EGF receptor and ErbB2 protects intestinal epithelial cells from TNF-induced apoptosis. Proc Natl Acad Sci U S A (2008) 1.58

Transactivation of the epidermal growth factor receptor in colonic epithelial cells by carbachol requires extracellular release of transforming growth factor-alpha. J Biol Chem (2002) 1.42

Expression of the c-erbB-4/HER4 protein and mRNA in normal human fetal and adult tissues and in a survey of nine solid tumour types. J Pathol (1998) 1.41

Neuregulin-4: a novel growth factor that acts through the ErbB-4 receptor tyrosine kinase. Oncogene (1999) 1.34

Understanding the susceptibility of the premature infant to necrotizing enterocolitis (NEC). Pediatr Res (2008) 1.34

The ErbB4 growth factor receptor is required for colon epithelial cell survival in the presence of TNF. Gastroenterology (2008) 1.29

Enterobacter sakazakii: an emerging pathogen in infants and neonates. Surg Infect (Larchmt) (2008) 1.22

Tumor-specific apoptosis caused by deletion of the ERBB3 pseudo-kinase in mouse intestinal epithelium. J Clin Invest (2009) 1.20

Epidermal growth factor/TNF-α transactivation modulates epithelial cell proliferation and apoptosis in a mouse model of parenteral nutrition. Am J Physiol Gastrointest Liver Physiol (2011) 1.19

Heparin-binding epidermal growth factor-like growth factor promotes enterocyte migration and proliferation in neonatal rats with necrotizing enterocolitis. J Pediatr Surg (2007) 1.15

Enterobacter sakazakii enhances epithelial cell injury by inducing apoptosis in a rat model of necrotizing enterocolitis. J Infect Dis (2008) 1.14

Role of the host defense system and intestinal microbial flora in the pathogenesis of necrotizing enterocolitis. Surg Infect (Larchmt) (2009) 1.14

Epidermal growth factor reduces intestinal apoptosis in an experimental model of necrotizing enterocolitis. Am J Physiol Gastrointest Liver Physiol (2004) 1.12

Reduction of experimental necrotizing enterocolitis with anti-TNF-alpha. Am J Physiol Gastrointest Liver Physiol (2005) 1.10

Heparin-binding EGF-like growth factor protects intestinal stem cells from injury in a rat model of necrotizing enterocolitis. Lab Invest (2011) 1.08

Heparin-binding epidermal growth factor-like growth factor overexpression in transgenic mice increases resistance to necrotizing enterocolitis. J Pediatr Surg (2010) 1.07

Concern Lactobacillus bulgaricus prevents intestinal epithelial cell injury caused by Enterobacter sakazakii-induced nitric oxide both in vitro and in the newborn rat model of necrotizing enterocolitis. Infect Immun (2008) 1.06

Enteric defensin expression in necrotizing enterocolitis. Pediatr Res (1998) 1.05

Absence of lysozyme (muramidase) in the intestinal Paneth cells of newborn infants with necrotising enterocolitis. J Clin Pathol (1998) 1.03

Increased epidermal growth factor levels in human milk of mothers with extremely premature infants. Pediatr Res (2003) 1.02

Heparin-binding epidermal growth factor-like growth factor reduces intestinal apoptosis in neonatal rats with necrotizing enterocolitis. J Pediatr Surg (2006) 1.01

Paneth cell ablation in the presence of Klebsiella pneumoniae induces necrotizing enterocolitis (NEC)-like injury in the small intestine of immature mice. Dis Model Mech (2012) 1.01

Paneth cells and necrotizing enterocolitis: a novel hypothesis for disease pathogenesis. Neonatology (2012) 1.00

Selective killing of Paneth cells by intravenous administration of dithizone in rats. Int J Exp Pathol (1991) 0.99

Shp2/MAPK signaling controls goblet/paneth cell fate decisions in the intestine. Proc Natl Acad Sci U S A (2014) 0.96

Necrotizing enterocolitis in the extremely low birth weight infant. J Pediatr Surg (1994) 0.96

Paneth cells and antibacterial host defense in neonatal small intestine. Infect Immun (2005) 0.95

Neuregulin-4 is a survival factor for colon epithelial cells both in culture and in vivo. J Biol Chem (2012) 0.92

Specific epidermal growth factor receptor autophosphorylation sites promote mouse colon epithelial cell chemotaxis and restitution. Am J Physiol Gastrointest Liver Physiol (2011) 0.91

ErbB4 promotes cyclooxygenase-2 expression and cell survival in colon epithelial cells. Lab Invest (2010) 0.90

Role of epidermal growth factor and other growth factors in the prevention of necrotizing enterocolitis. Semin Perinatol (2008) 0.89

Necrotizing enterocolitis: role of platelet activating factor, endotoxin, and tumor necrosis factor. J Pediatr (1990) 0.88

TNF-α converting enzyme-mediated ErbB4 transactivation by TNF promotes colonic epithelial cell survival. Am J Physiol Gastrointest Liver Physiol (2011) 0.87

ErbB2 and ErbB3 regulate recovery from dextran sulfate sodium-induced colitis by promoting mouse colon epithelial cell survival. Lab Invest (2011) 0.87

Protective effect of tumor necrosis factor alpha antibody on experimental necrotizing enterocolitis in the rat. J Pediatr Surg (2005) 0.86

Heparin-binding EGF-like growth factor is present in human amniotic fluid and breast milk. J Pediatr Surg (2002) 0.83

Growth factor concentrations and growth-promoting activity in human milk following premature birth. J Dev Physiol (1985) 0.83

NEC, EGF, milk, and spit. Gastroenterology (2002) 0.76